Company Overview and News

 
HCC rises 2% as co files draft letter of offer with SEBI exchanges for rights issue

2018-09-14 moneycontrol
Shares of Hindustan Construction Company (HCC) rose 2.6 percent intraday Friday as company filed draft letter of offer with SEBI & exchanges for rights issue.
HIN 500185 HCC

 
Company news: Hindustan Construction Company

2018-09-05 thehindubusinessline
The board of Hindustan Construction Company on Wednesday approved a ₹500-crore rights issue. For the purpose of giving effect to the issue, the board has constituted a special committee – the rights issue committee, which has been authorised to finalise the terms and conditions, including entitlement ratio, price, record date, timing and all other related matters. Shares of HCC closed at ₹14.45, down 1.
HIN 500185 HCC

 
HCC to raise Rs 500 crore through rights issue

2018-09-05 moneycontrol
Hindustan Construction Company (HCC) said Wednesday its board has approved plan to raise up to Rs 500 crore from its existing shareholders.
HIN 500185 HCC

 
Hindustan Construction: Board meet for QIP issue

2018-09-04 thehindubusinessline
The board of Hindustan Construction Company will meet on Wednesday to consider a fund-raising proposal. The company may consider issue of equity shares or other securities, including through qualified institutional placement, rights issue, preferential issue or through any other permissible mode or combination thereof. Investors would be keen to know the issue size and the mode of fund-raising. Besides, issue price will also be on shareholders’ radars.
HIN 500185 HCC

 
An evening walk down Dalal Street | Selling across the board drags Nifty below 11,600, Sensex closes over 300 points lower

2018-09-03 moneycontrol
It was an anti-climax for the market on Monday, as benchmarks closed nowhere near to the levels they had opened at. In fact, a sharp selloff in the last hour erased all the gains, with the market closing at low points of the day. The Nifty managed to give up 11,600, while the Sensex fell around 300 points.
BAJAJ-AUTO AXB IBN UBL 533262 UBHOLDINGS 532977 HIN UNBWY 532215 532478 AXBKY AXBA ICICIBANK RAMKY BAJFINANCE AXISBANK 532174 BJJQY 500185 507458 HCC 500034

 
HCC gains 8% as board to consider fund raising on September 5

2018-09-03 moneycontrol
Shares of Hindustan Construction Company (HCC) gained 8.5 percent intraday Monday as company board to consider fund raising on September 5.
HIN 500185 HCC

2
Hindustan Construction tanks 9%

2018-08-31 thehindubusinessline
Lavasa Corporation Ltd is jointly held by Hindustan Construction Company Limited (68.7 per cent), Avantha Group (17.18 per cent), Venkateshwara Hatcheries (7.81 per cent) and Vithal Maniar (6.29 per cent).
YESBANK WIT IDEA ICLQY 532648 HIN YYBKY 532822 500185 HCC

1
Market Live: Banks, metals drag D-Street from high points, Nifty gives up 11,700; Sensex down 100 points

2018-08-31 moneycontrol
Share price of Dr Reddy's Laboratories gained 2.7 percent intraday Friday as foreign research house BofAML has maintained buy rating on the stock.
BHRYY 500325 RELIANCE 532617 ICLQY 532215 AXISBANK 534816 RIGD INFRATEL HCC RLNIY YESBANK VOD AXB VOD JETAIRWAYS 532648 YYBKY HIN 532822 AXBKY AXBA VODPF IDEA 500185

1
Market Live: Banks, metals drag D-Street from high points, Nifty gives up 11,700

2018-08-31 moneycontrol
Market Update: Equities have given up all their gains on Friday morning, with the Nifty trading below 11,700. A sharp selloff in metals, banks as well as energy names is weighing on indices. Meanwhile, pharmaceuticals continue to trade higher, led by gains in Sun Pharmaceuticals.
BHRYY 500325 RELIANCE 532617 ICLQY 532215 AXISBANK 534816 RIGD INFRATEL HCC RLNIY YESBANK VOD AXB VOD JETAIRWAYS 532648 YYBKY HIN 532822 AXBKY AXBA VODPF IDEA 500185

3
Lavasa Corporation to face insolvency

2018-08-31 moneycontrol
Construction firm HCC's real estate firm Lavasa Corporation will face insolvency proceedings with the NCLT on August 30 admitting plea of lenders of the debt-ridden realty firm. Lavasa Corporation is developing a hill city 'Lavasa' near Pune in Maharashtra.
BRK.A HIN 500185 HCC

 
BMC’s key coastal road work from Princess Street Flyover to Worli end of Bandra-Worli Sea Link will start in October

2018-08-20 freepressjournal.in
Mumbai: The Brihanmumbai Municipal Corporation (BMC) has finalised the contractors to build all the three portions of the first phase of the civic body’s ambitious coastal road project. Come October, the BMC will supposedly begin work for the 9.98-km first phase of the stretch that will run along the western coast of Mumbai.
HIN 500185 HCC

 
HCC posts net loss of Rs 19.7 cr in Jun qtr

2018-08-08 moneycontrol
Infrastructure firm Hindustan Construction Company (HCC) today reported a standalone net loss of Rs 19.7 crore for the June quarter, mainly due to rise in expenses.
HIN 500185 HCC

 
Lenders must evaluate resolution of insolvent EPC firms on case-to-case basis

2018-07-31 livemint
Since the introduction of the Insolvency and Bankruptcy Code, 2016 (IBC), a large number of corporate debtors rather than seeing revival have been pushed into liquidation. In case of an engineering, procurement and construction (EPC) firm, the value of its business as a going concern is largely driven by the three core assets: (a) “PQs (pre-qualifications)” being technical qualifications/credentials, on basis of which an EPC firm qualifies to bid for infrastructure projects; (b) “order book” representing the ongoing infrastructure projects, which also represents future receivables of an EPC firm; and (c) “key personnel” being personnel/staff, who have the requisite expertise for implementing the project.
531120 GAMMONIND 509550 PATELENG HIN 500185 HCC

 
Biggest losers: These 10 stocks have lost over 50% in the past 6 months

2018-06-30 moneycontrol
The first half of CY 2018 saw the Sensex hit a peak of 36,443 and many stocks gave high returns. However, the value of these 10 stocks plunged drastically over the past six months. The market cap of these companies is above Rs 1,000 crore. Check out how much percent these stocks have fallen. All figures are year-to-date (YTD) as of June 22, 2018. (Image: Reuters)
HIN 500185 HCC

 
Billionaire’s Folly Becomes Bankers’ Nightmare - Bloomberg

2018-06-23 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HIN 500185 HCC

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

11h - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

11h - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

13h - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...